METHOD AND SYSTEM FOR RISK STRATIFICATION AND CHEMOTHERAPY RESISTANCE PREDICTION IN PANCREATIC DUCTAL ADENOCARCINOMA

Abstract

An exemplary system and method for predicting treatment-related outcomes of patients after a cancer therapy and/or treatment (e.g., PDA treatment) using DNA (e.g., cell-free DNA (cfDNA)) or RNA methylation signatures and/or an RNA sequencing signature as predictive biomarkers for treatment response and overall survival in the patients.

CPC Classifications